Journal of the Neurological Sciences

It's tricky: Rating alleviating maneuvers in cervical dystonia.  419. 2020

Vascular-brain Injury Progression after Stroke (VIPS) study: concept for understanding racial and geographic determinants of cognitive decline after stroke.  412. 2020

Genetic risk of Spontaneous intracerebral hemorrhage: Systematic review and future directions.  407. 2019

Physical activity, sedentary behavior, and restless legs syndrome in persons with multiple sclerosis.  407. 2019

Epilepsy treatment patterns among patients with tuberous sclerosis complex.  391:104-108. 2018

Advancing stroke genomic research in the age of Trans-Omics big data science: Emerging priorities and opportunities.  382:18-28. 2017

Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence.  380:38-43. 2017

Interleukin–6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men.  379:229-235. 2017

Caffeine, creatine, GRIN2A and Parkinson's disease progression.  375:355-359. 2017

Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population.  375:371-375. 2017

Olfactory ability in normal pressure hydrocephalus as compared to Alzheimer's disease and healthy controls.  372:217-219. 2017

Physical activity, sedentary behavior, and aerobic capacity in persons with multiple sclerosis.  372:342-346. 2017

Brain activation changes during locomotion in middle-aged to older adults with multiple sclerosis.  370:277-283. 2016

Dissociation among hemodynamic measures in asymptomatic high grade carotid artery stenosis.  367:143-147. 2016

Evaluating the single seizure clinic model: Findings from a Canadian Center.  367:203-210. 2016

Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.  366:213-223. 2016

Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial.  365:190-198. 2016

Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.  363:225-231. 2016

Gut microbiota composition and relapse risk in pediatric MS: A pilot study.  363:153-157. 2016

Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.  362:121-126. 2016

Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status.  361:95-100. 2016

Itemized NIHSS subsets predict positive MRI strokes in patients with mild deficits.  358:221-225. 2015

Pallidal and caudate volumes correlate with walking function in multiple sclerosis.  354:33-36. 2015

The safety of exercise training in multiple sclerosis: A systematic review.  343:3-7. 2014

Accelerometer cut-points derived during over-ground walking in persons with mild, moderate, and severe multiple sclerosis.  340:50-57. 2014

Investigating the minimal important difference in ambulation in multiple sclerosis: A disconnect between performance-based and patient-reported outcomes?.  347:268-274. 2014

Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.  335:169-173. 2013

Dual task cost of walking is related to fall risk in persons with multiple sclerosis.  335:160-163. 2013

Gait and six-minute walk performance in persons with multiple sclerosis.  334:72-76. 2013

Psychometric properties of the Fatigue Severity Scale and the Modified Fatigue Impact Scale.  331:102-107. 2013

Physical fitness, walking performance, and gait in multiple sclerosis.  328:70-76. 2013

Creative innovation with temporal lobe epilepsy and lobectomy.  324:45-48. 2013

The dynamics of finger tremor in multiple sclerosis is affected by whole body position.  324:84-89. 2013

Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis.  323:123-127. 2012

Impaired cognitive function in patients with atherosclerotic carotid stenosis and correlation with ultrasound strain measurements.  322:20-24. 2012

Increasing age at disability milestones among MS patients in the MSBase Registry.  318:94-99. 2012

Postural control in multiple sclerosis: Effects of disability status and dual task.  315:44-48. 2012

Implementing clinical trials on an international platform: Challenges and perspectives.  313:1-6. 2012

Pulse pressure is associated with walking impairment in multiple sclerosis.  309:105-109. 2011

Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.  307:22-29. 2011

Anxiety and depression severity are related to right but not left onset Parkinson's disease duration.  305:131-135. 2011

Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12.  305:75-79. 2011

Post-streptococcal vasculopathy with evolution to Degos' disease.  300:157-159. 2011

GABAergic but not anti-cholinergic agents re-induce clinical deficits after stroke.  292:72-76. 2010

Accelerometry in persons with multiple sclerosis: Measurement of physical activity or walking mobility?.  290:6-11. 2010

Continued validation of the Symptom Inventory in multiple sclerosis.  285:134-136. 2009

Artistic creativity and DBS: A case report.  276:138-142. 2009

Creativity in Parkinson's disease as a function of right versus left hemibody onset.  276:179-183. 2009

Pooled analysis of patients with thunderclap headache evaluated by CT and LP: Is angiography necessary in patients with negative evaluations?.  276:123-125. 2009

Intravenous thrombolysis followed by intra-arterial thrombolysis and mechanical thrombectomy for the treatment of pediatric ischemic stroke.  275:151-153. 2008

Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).  268:69-73. 2008

Chronic inflammatory demyelinating polyradiculoneuropathy presenting as cauda equina syndrome in a diabetic.  260:267-270. 2007

CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease.  225:79-83. 2004

Optimizing immunomodulatory therapy for MS patients: An integrated management model.  201:89-90. 2002

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.  173:32-39. 2000

Elevated cerebrospinal fluid and serum nitrate and nitrite levels in patients with central nervous system complications of HIV-1 infection: A correlation with blood-brain-barrier dysfunction.  156:53-58. 1998

Raised serum nitrate and nitrite levels in patients with multiple sclerosis.  145:77-81. 1997

Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα).  138:134-144. 1996

The electroencephalogram in neglect.  34:343-348. 1977

A memory defect in uremic encephalopathy.  26:245-249. 1975